Sleep Apnea: The Complete Guide to Symptoms, Diagnosis, and Treatment
Obstructive sleep apnea affects an estimated 30 million adults in the United States, and roughly 80% of moderate-to-severe cases remain undiagnosed. That is not a rounding error. It means millions of people are living with a condition that fragments their sleep, starves their blood of oxygen dozens of times per hour, and steadily increases their risk of hypertension, stroke, heart failure, and Type 2 diabetes — and they have no idea it is happening. Many of them have been told they snore. Some have been told they seem tired. Almost none of them connect those observations to a treatable medical condition.
This guide covers what obstructive sleep apnea actually is, how it differs from the central and mixed subtypes, what the symptoms look like beyond the obvious ones, how the diagnostic process works from screening questionnaires through polysomnography, and every major treatment option from CPAP to oral appliances to surgical intervention. It draws on published clinical research, current American Academy of Sleep Medicine (AASM) guidelines, and interviews with board-certified sleep medicine physicians. If you suspect you have sleep apnea or if someone close to you does, this is the resource you need.
What Happens During an Apnea Event
An apnea event occurs when the muscles in the back of the throat relax during sleep and collapse inward, partially or completely blocking the upper airway. The airway does not close because something is wrong with the muscles themselves. It closes because the normal loss of muscle tone during sleep — a process called atonia — reduces the structural support that keeps the airway open when you are awake. In people with obstructive sleep apnea, the airway is either anatomically narrow to begin with or the surrounding tissue is heavier than the remaining muscle tone can support.
When the airway closes, airflow stops. The diaphragm continues to contract, pulling against a sealed passage. Oxygen saturation in the blood begins to drop. Carbon dioxide levels rise. Within 10 to 40 seconds, the brain detects the chemical imbalance and triggers a brief arousal — not a full awakening, but a shift from deeper sleep to a lighter stage, just long enough for the throat muscles to regain tone and reopen the airway. The sleeper gasps, takes several deep breaths, and drifts back into deeper sleep. The cycle begins again.
In moderate obstructive sleep apnea, this happens 15 to 30 times per hour. In severe cases, it can exceed 60 events per hour — once a minute, all night long. Each arousal is too brief to produce a conscious memory, so the person wakes up in the morning believing they slept through the night. They did not. Their sleep architecture has been shattered into fragments no longer than a few minutes each, and they have spent the night cycling between oxygen deprivation and partial awakening without any awareness that it happened.
Symptoms You Might Miss
The signature symptom of obstructive sleep apnea is loud, chronic snoring punctuated by pauses and gasps. But plenty of people with sleep apnea do not snore loudly enough to disturb a partner, and some do not snore at all. Relying on snoring as the primary indicator misses a substantial portion of cases, particularly in women, who are less likely to present with the stereotypical heavy-snoring profile.
Excessive daytime sleepiness is the second hallmark, but it is also easy to explain away. Adults with untreated sleep apnea often attribute their fatigue to stress, poor fitness, aging, or simply not being morning people. They drink more coffee. They push through afternoon slumps. They normalize a level of tiredness that would seem alarming if they had ever experienced what genuinely restorative sleep feels like.
Beyond snoring and fatigue, the symptom list extends into territory most people would never connect to a sleep disorder. Morning headaches — dull, bilateral, lasting 30 to 60 minutes after waking — result from the overnight CO2 retention and cerebral vasodilation that accompany repeated apneas. Nocturia, or waking two or more times per night to urinate, occurs because the intrathoracic pressure swings during obstructed breathing trigger the release of atrial natriuretic peptide, which increases urine production. Bruxism, or teeth grinding, is present in roughly 25% of obstructive sleep apnea patients, likely as a reflexive jaw-clenching response to airway obstruction. Dry mouth on waking indicates mouth breathing, which itself is a compensatory response to nasal airway resistance that worsens apnea.
Cognitive symptoms are equally common and equally underrecognized. Difficulty concentrating, short-term memory lapses, irritability, and depressed mood are all documented consequences of the chronic sleep fragmentation and intermittent hypoxia that characterize untreated sleep apnea. A study by Lal, Strange, and Bachman published in Chest (2012) found that patients with untreated moderate-to-severe sleep apnea performed significantly worse on tests of attention, executive function, and working memory compared to age-matched controls — deficits that resolved within three months of consistent CPAP use.
Who Is at Risk
The strongest risk factor for obstructive sleep apnea is excess body weight. Adipose tissue deposited around the neck and pharynx narrows the airway and increases its collapsibility. A neck circumference greater than 17 inches in men or 16 inches in women is a significant predictor, independent of overall BMI. However, sleep apnea is not exclusively a condition of overweight individuals. Approximately 20% of patients with moderate-to-severe obstructive sleep apnea have a normal BMI. In these cases, craniofacial anatomy — a retrognathic jaw, a narrow palate, enlarged tonsils, or a long soft palate — is typically the primary contributor.
Age increases risk progressively. The prevalence of at least mild obstructive sleep apnea roughly doubles between ages 30 and 60, driven by age-related loss of muscle tone in the pharyngeal dilator muscles. Male sex is a risk factor, with men approximately twice as likely to be diagnosed as premenopausal women, though the gap narrows significantly after menopause, suggesting a protective role for progesterone and estrogen in maintaining upper airway patency.
Family history matters. Twin studies and genome-wide association studies have identified heritable craniofacial traits — jaw position, palate width, airway shape — that predispose to airway collapse. If a first-degree relative has been diagnosed with obstructive sleep apnea, your risk is approximately two to four times higher than the general population, even after adjusting for shared environmental factors like diet and activity level.
Alcohol consumption, sedative medications, and sleeping in the supine position all worsen obstructive sleep apnea by further reducing pharyngeal muscle tone. In some patients, apnea events occur almost exclusively while sleeping on the back, a subtype called positional obstructive sleep apnea that responds to targeted interventions.
How Diagnosis Actually Works
The diagnostic pathway begins with a clinical evaluation, usually triggered by a bed partner's observation, a patient's complaint of excessive daytime sleepiness, or a screening questionnaire administered during a routine medical visit. The STOP-BANG questionnaire — eight yes-or-no questions covering snoring, tiredness, observed apneas, blood pressure, BMI, age, neck circumference, and gender — is the most widely validated screening tool. A score of 5 or higher has a sensitivity exceeding 90% for moderate-to-severe obstructive sleep apnea.
The gold standard for diagnosis is in-laboratory polysomnography (PSG): an overnight study in a sleep center where electroencephalography, electromyography, electrooculography, nasal airflow, thoracic and abdominal effort, pulse oximetry, body position, and snoring sounds are all recorded simultaneously. A trained technologist monitors the study in real time and can intervene if oxygen saturation drops to dangerous levels. The data produces an Apnea-Hypopnea Index, a measure of respiratory disturbance during sleep, along with detailed information about sleep architecture, arousal patterns, and oxygen desaturation profiles.
For patients with a high pretest probability and no significant comorbidities, the AASM now endorses home sleep apnea testing (HSAT) as an acceptable alternative to in-laboratory PSG. Home tests are simpler — typically measuring nasal airflow, respiratory effort, and pulse oximetry without EEG — and substantially cheaper. However, they tend to underestimate apnea severity because they cannot distinguish between sleep and quiet wakefulness. A negative home test in a patient with high clinical suspicion should be followed by in-laboratory PSG, not taken as a final answer.
CPAP: The First-Line Treatment
Continuous positive airway pressure remains the first-line treatment for moderate-to-severe obstructive sleep apnea and the treatment with the strongest evidence base. A CPAP machine delivers a continuous stream of pressurized air through a mask worn during sleep. The air pressure acts as a pneumatic splint, holding the airway open against the collapsing force of the relaxed pharyngeal muscles. When the pressure is properly titrated, it eliminates apnea events entirely. The effect is immediate: patients who use CPAP on their first night in a sleep lab often report feeling dramatically more rested the following morning.
The challenge with CPAP is adherence. Published adherence rates vary, but the most commonly cited figure is that roughly 50% of patients prescribed CPAP are using it for the Medicare-defined minimum of four hours per night on at least 70% of nights after one year. That figure understates actual usage in motivated patients with proper support, but it reflects a real problem: CPAP can be uncomfortable, claustrophobic, noisy, and disruptive to bed partners. Mask fit is the single largest determinant of adherence. A mask that leaks, shifts during sleep, or creates pressure sores on the bridge of the nose will be abandoned within weeks.
Modern CPAP machines bear little resemblance to the devices of 20 years ago. Current-generation units are whisper-quiet (26–30 dBA), humidified, auto-titrating (they adjust pressure breath-to-breath based on detected flow limitation), and connected to smartphone apps that provide nightly data on usage, mask seal, and residual AHI. The ResMed AirSense 11 and Philips Respironics DreamStation 2 are the two dominant platforms, and both have been validated in randomized controlled trials showing significant reductions in AHI, daytime sleepiness, and blood pressure with consistent use.
Mask selection deserves its own discussion. Nasal masks cover only the nose and are generally the most comfortable and best-tolerated option, but they require the user to keep their mouth closed during sleep — a chin strap or mouth-taping practice may be necessary. Nasal pillow masks seal at the nostrils rather than over the nose bridge and work well for patients who feel claustrophobic in larger masks. Full-face masks cover both the nose and mouth and are necessary for patients who breathe through their mouth during sleep, but they tend to have higher leak rates and lower long-term adherence.
Beyond CPAP: Alternative Treatments
For patients who cannot tolerate CPAP, or for mild-to-moderate cases where CPAP may be more intervention than necessary, several alternatives exist with varying levels of evidence.
Oral appliances — specifically mandibular advancement devices (MADs) — are the leading CPAP alternative. These custom-fitted dental devices hold the lower jaw in a slightly forward position during sleep, which opens the retroglossal airway space and reduces collapsibility. Randomized controlled trials comparing MADs to CPAP show that MADs are less effective at reducing AHI (typical reductions of 50–60% versus near-100% for CPAP) but have significantly higher adherence rates. For mild-to-moderate obstructive sleep apnea, the net clinical benefit of a MAD worn consistently can match or exceed that of a CPAP used only intermittently.
Positional therapy targets the subset of patients whose apnea events occur predominantly in the supine position. Devices range from simple tennis-ball-in-a-pocket vests to FDA-cleared wearable vibrotactile sensors that detect supine sleep and deliver a gentle vibration to prompt a position change without waking the sleeper. For patients with clearly positional obstructive sleep apnea, these devices can reduce AHI by 50% or more with minimal side effects.
Hypoglossal nerve stimulation (Inspire therapy) is a surgically implanted device that stimulates the hypoglossal nerve during sleep, causing the tongue to move forward and open the airway. It is FDA-approved for patients with moderate-to-severe obstructive sleep apnea who have failed CPAP therapy and meet specific anatomical criteria (most importantly, they cannot have concentric collapse at the level of the soft palate, which is assessed by drug-induced sleep endoscopy). The STAR trial, published in the New England Journal of Medicine in 2014, showed a 68% reduction in median AHI at 12 months with high patient satisfaction. Five-year follow-up data confirmed durable efficacy.
Weight loss is the only intervention that addresses the most common underlying cause of obstructive sleep apnea in overweight patients. A 10% reduction in body weight typically produces a 26% reduction in AHI, and in some patients, sufficient weight loss can cure the condition entirely. The recent introduction of GLP-1 receptor agonists (semaglutide, tirzepatide) has made medically-supported weight loss more achievable for many patients, and early clinical data suggest that the AHI reductions associated with GLP-1-mediated weight loss are clinically significant.
Surgery remains an option for patients with identifiable anatomical obstruction. Uvulopalatopharyngoplasty (UPPP) removes excess tissue from the soft palate and pharynx but has modest long-term success rates (40–60% reduction in AHI). Maxillomandibular advancement, which repositions both jaws forward to enlarge the entire upper airway, has higher efficacy (80–90% success rates) but is a major procedure with a recovery period of six to eight weeks. Tonsillectomy and adenoidectomy can be curative in patients — particularly younger adults — with significant tonsillar hypertrophy contributing to airway obstruction.
Long-Term Health Consequences of Untreated Sleep Apnea
The cardiovascular consequences of untreated obstructive sleep apnea are well established. The Wisconsin Sleep Cohort Study, an 18-year prospective study published in Sleep in 2008, found that untreated severe obstructive sleep apnea was associated with a threefold increase in all-cause mortality, driven primarily by cardiovascular events. The mechanism involves repeated cycles of hypoxia and reoxygenation that trigger oxidative stress, systemic inflammation, sympathetic nervous system activation, and endothelial dysfunction — a combination that accelerates atherosclerosis and promotes arrhythmias.
Hypertension is present in approximately 50% of obstructive sleep apnea patients, and obstructive sleep apnea is the most common identifiable cause of resistant hypertension (blood pressure that remains elevated despite three or more antihypertensive medications). Treatment of obstructive sleep apnea with CPAP produces a modest but consistent reduction in blood pressure, typically 2–4 mmHg for systolic and 1–2 mmHg for diastolic, with larger effects in patients who use CPAP for more than four hours per night.
Atrial fibrillation occurs at roughly double the rate in obstructive sleep apnea patients compared to matched controls. The intrathoracic pressure swings generated by breathing against a closed airway stretch the atrial walls and create the substrate for reentrant arrhythmias. Patients who undergo cardioversion or ablation for atrial fibrillation and have untreated sleep apnea have significantly higher recurrence rates than those whose sleep apnea is treated.
Type 2 diabetes risk is elevated in obstructive sleep apnea independent of obesity. Intermittent hypoxia impairs insulin sensitivity and glucose metabolism through mechanisms that include increased cortisol secretion, sympathetic activation, and inflammatory cytokine release. The International Diabetes Federation recommends screening all patients with Type 2 diabetes for obstructive sleep apnea, and vice versa.
The cognitive consequences extend beyond the acute effects of sleep fragmentation. Emerging research using neuroimaging has documented structural changes in the brains of patients with chronic untreated sleep apnea, including reductions in gray matter volume in the hippocampus, frontal cortex, and cerebellum. These changes are partially reversible with treatment, but the degree of recovery decreases with the duration of untreated disease.
Living With CPAP: Practical Tips From Long-Term Users
The transition to CPAP therapy is easier for some patients than others, but nearly every long-term user went through an adjustment period. The most common complaints during the first two to four weeks are mask discomfort, air leaks, nasal congestion, aerophagia (swallowing air, which causes bloating), and difficulty falling asleep with the device. Here is what experienced users and sleep clinicians recommend.
Start by wearing the mask during the day while watching television or reading. This desensitization step reduces the anxiety response that many people experience when a mask is placed over their face in a dark room. Fifteen to twenty minutes of daytime wear for three to five days before the first overnight use can significantly improve first-night tolerance.
Use the ramp feature. Most modern CPAP machines can start at a lower pressure and gradually increase to the therapeutic setting over 15 to 30 minutes, allowing you to fall asleep before the pressure reaches its full level. Auto-titrating machines take this further by adjusting pressure throughout the night, delivering only as much pressure as needed at any given moment.
Heated humidification is not optional. Dry, pressurized air passing through the nasal passages causes mucosal drying, congestion, and nosebleeds. Every current-generation CPAP machine includes an integrated heated humidifier, and using it from the first night eliminates or reduces these symptoms for the vast majority of patients.
If nasal congestion persists despite humidification, a saline nasal spray before bed and a short course of nasal corticosteroid spray (fluticasone, mometasone) can resolve the issue. Chronic nasal obstruction that does not respond to these measures warrants evaluation by an otolaryngologist, as a deviated septum or turbinate hypertrophy may be contributing to both the nasal congestion and the sleep apnea itself.
Replace the mask cushion on the manufacturer's recommended schedule — typically every one to three months. Silicone degrades with nightly use, and a cushion that sealed perfectly in month one may develop persistent leaks by month four. Most insurance plans cover regular replacement supplies.
When to See a Doctor
You should seek evaluation for obstructive sleep apnea if you experience any combination of the following: loud habitual snoring, witnessed breathing pauses during sleep, excessive daytime sleepiness that does not improve with adequate sleep duration, morning headaches, nocturia, or unexplained difficulty concentrating. If you have been diagnosed with resistant hypertension, atrial fibrillation, or Type 2 diabetes, ask your physician about sleep apnea screening regardless of whether you have obvious sleep-related symptoms.
The evaluation begins with your primary care physician, who can administer a screening questionnaire and refer you for a sleep study. Many patients can complete a home sleep test, which involves wearing a portable monitor for one to three nights and returning it to the sleep center for interpretation. If the results are inconclusive or if you have comorbidities that require closer monitoring, an in-laboratory polysomnography will be scheduled.
Do not defer the evaluation. The average time from symptom onset to diagnosis of obstructive sleep apnea in the United States is approximately five years. During that interval, untreated patients accumulate cardiovascular risk, cognitive decline, and reduced quality of life that is largely preventable with treatment. The diagnostic process is straightforward, noninvasive, and covered by most insurance plans. The treatment works. The only step that requires initiative is making the appointment.
